製品の概要

製品の詳細

  • 由来Synthetic
  • 由来CHO cells

特性

Our Abpromise guarantee covers the use of ab13718 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-AICDA antibody - ChIP Grade (ab5197)

  • 製品の状態Liquid
  • 備考

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

関連情報

  • 別名
    • Activation induced cytidine deaminase
    • Activation induced deaminase
    • Activation-induced cytidine deaminase
    • AICDA
    • AICDA_HUMAN
    • AID
    • ARP 2
    • ARP2
    • CDA 2
    • CDA2
    • Cytidine aminohydrolase
    • HIGM2
    • Integrated into Burkitt's lymphoma cell line Ramos
    see all
  • 機能RNA-editing deaminase involved in somatic hypermutation, gene conversion, and class-switch recombination. Required for several crucial steps of B-cell terminal differentiation necessary for efficient antibody responses.
  • 組織特異性Strongly expressed in lymph nodes and tonsils.
  • 関連疾患Defects in AICDA are the cause of hyper-IgM immunodeficiency syndrome type 2 (HIGM2) [MIM:605258]; also known as hyper-IgM syndrome 2. HIGM2 is an autosomal recessive disorder characterized by normal or elevated serum IgM levels with absence of IgG, IgA, and IgE, resulting in a profound susceptibility to bacterial infections. HIGM2 causes the absence of Ig class switch recombination (CSR), the lack of Ig somatic hypermutations, and lymph node hyperplasia caused by the presence of giant germinal centers.
  • 配列類似性Belongs to the cytidine and deoxycytidylate deaminase family.
  • Information by UniProt

Human AICDA peptide (ab13718) 使用論文

ab13718 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab13718.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"